Drug ID: | NPD7096 |
Drug Name: | |
Molecular Formula: | C28H36O7 |
Canonical SMILES: | CCCc1c(OCCCOc2ccc(c(c2CCC)OC)C(=O)C)ccc2c1OC(CC2)C(=O)O |
Standard InCHI: | InChI=1S/C28H36O7/c1-5-8-21-23(13-10-19-11-14-25(28(30)31)35-26(19)21)33-16-7-17-34-24-15-12-20(18(3)29)27(32-4)22(24)9-6-2/h10,12-13,15,25H,5-9,11,14,16-17H2,1-4H3,(H,30,31) |
Standard InCHIKey: | ZVVCSBSDFGYRCB-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB007307; DCL000070 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 114999 |
ChEBI | |
CAS Number |
Molecular Weight | 484.25 |
ALogP | -2.0039 |
MLogP | 3.77 |
XLogP | 5.646 |
HDA | 3 |
HBD | 1 |
Rotatable Bonds | 18 |
TPSA | 91.29 |
RO5 Violation | 2 |